A recent study reported that the levels of circulating CD4+IL−17+ T cells are substantially higher in rejection group than in non-rejection group in liver transplant recipients, and the frequency of CD4+IL−17+ cells in peripheral blood is positively correlated with the rejection activity index [43]. Here, IL17A is linked to digestive system neoplasm.